Matching slides 42,534
Current window 30,391-30,420
Pages 1,418
Rows per page 30
Beat: Resolutionclear collectionreset all

Beat

30,391-30,420 of 42,534

filter-aware
14
Advantage Solutions | Results Presentation Deck | 14 slidesAdvantage Solutions | Results Presentation Deck | 14 slides · Advantage Solutions
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
10
Aeva | Results Presentation Deck | 12 slidesAeva | Results Presentation Deck | 12 slides · Aeva
Conference presentation Investor relations Beat · Action1 hit
11
Includes footnotes explaining non-GAAP adjustments and capital expenditure details.Aeva | Results Presentation Deck | 12 slides · Aeva
Conference presentation Investor relations Beat · Action1 hit
12
Aeva | Results Presentation Deck | 12 slidesAeva | Results Presentation Deck | 12 slides · Aeva
Conference presentation Investor relations Beat · Action1 hit
14
Allego | Results Presentation Deck | 16 slidesAllego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
15
The table includes both historical full-year data (2020-2022) and half-year data (H1 2022, H1 2023).Allego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
16
Allego | Results Presentation Deck | 16 slidesAllego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
09
The slide highlights the mechanism of action targeting multiple HBV transcripts.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
10
The slide outlines study design for Part 1, 2, and 3 of a clinical trial for chronic hepatitis B (cHBV).Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
11
Data presented at Global Hepatitis Summit 2023. Includes specific cohort N values and standard error (SE) in parentheses.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
12
The slide displays six longitudinal line charts representing different patient cohorts, with specific callouts for clinical outcomes.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
13
Clinical trial data showing individual patient responses over time.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
14
Data presented at EASL 2022. Shows correlation between T-cell activation and HBsAg reduction.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
32
The slide uses a before-after comparison structure to highlight changes in financial outlook.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · Action1 hit
33
Oatly | Results Presentation Deck | 38 slidesOatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · Action1 hit
34
Slide 34 of the presentation.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · Action1 hit
35
The slide uses pie charts to visualize the revenue split by channel (Food retail, Foodservice, Other) for three distinct regions.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · Action1 hit
36
The chart illustrates a net increase in gross margin from 15.8% to 19.2%.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · Action1 hit
37
The table shows revenue performance for EMEA, Americas, and Asia for the three months ended June 30, 2023 vs 2022.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · Action1 hit
38
The table reconciles non-IFRS measures to IFRS financial results, including adjustments for share-based compensation, restructuring costs, and transaction-related costs.Oatly | Results Presentation Deck | 38 slides · Oatly
Conference presentation Investor relations Beat · Action1 hit
15
The slide uses a narrative format to present financial guidance rather than a table.Snap Inc | Results Presentation Deck | 20 slides · Snap Inc.
Conference presentation Investor relations Beat · Action1 hit
16
Snap Inc | Results Presentation Deck | 20 slidesSnap Inc | Results Presentation Deck | 20 slides · Snap Inc.
Conference presentation Investor relations Beat · Action1 hit
17
Includes footnotes explaining the adjustments and definitions of non-GAAP measures.Snap Inc | Results Presentation Deck | 20 slides · Snap Inc.
Conference presentation Investor relations Beat · Action1 hit
18
Includes footnotes explaining the nature of adjustments and share count calculations.Snap Inc | Results Presentation Deck | 20 slides · Snap Inc.
Conference presentation Investor relations Beat · Action1 hit
19
Text-only back-of-book methodology/disclosure slide; no charts or numeric data points.Snap Inc | Results Presentation Deck | 20 slides · Snap Inc.
Conference presentation Investor relations Beat · Action1 hit
20
This is a standard legal/methodological disclosure slide often found in investor presentations or S-1 filings.Snap Inc | Results Presentation Deck | 20 slides · Snap Inc.
Conference presentation Investor relations Beat · Action1 hit
08
Talkspace | Results Presentation Deck | 11 slidesTalkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · Action1 hit
19
The slide outlines a shift from reporting costs by nature to reporting costs by function, effective 1H 2023.Zegna | Results Presentation Deck | 35 slides · Ermenegildo Zegna Group
Conference presentation Investor relations Beat · Action1 hit
20
The slide serves as a forward-looking statement update.Zegna | Results Presentation Deck | 35 slides · Ermenegildo Zegna Group
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
21
The slide includes the Ermenegildo Zegna Group logo and a page number.Zegna | Results Presentation Deck | 35 slides · Ermenegildo Zegna Group
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit